SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-043665
Filing Date
2012-08-08
Accepted
2012-08-08 16:30:33
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v318892_10q.htm 10-Q 389871
2 EXHIBIT 31.1 v318892_ex31-1.htm EX-31.1 9983
3 EXHIBIT 31.2 v318892_ex31-2.htm EX-31.2 9951
4 EXHIBIT 32.1 v318892_ex32-1.htm EX-32.1 3727
5 EXHIBIT 32.2 v318892_ex32-2.htm EX-32.2 3903
  Complete submission text file 0001144204-12-043665.txt   2719119

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kerx-20120630.xml EX-101.INS 256690
7 XBRL TAXONOMY EXTENSION SCHEMA kerx-20120630.xsd EX-101.SCH 25718
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20120630_cal.xml EX-101.CAL 37408
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20120630_def.xml EX-101.DEF 180808
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20120630_lab.xml EX-101.LAB 277553
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20120630_pre.xml EX-101.PRE 212064
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 121017204
SIC: 2834 Pharmaceutical Preparations